These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1023978)

  • 1. [Lethal infection with BCG in thymectomized mice].
    Moroz AM; Galkin IuM; Litvinov VI; Il'ina IN; Averbakh MM
    Biull Eksp Biol Med; 1976 Dec; 82(12):1464-5. PubMed ID: 1023978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antituberculosis immunity in adult thymectomized mice].
    Averbakh MM; Galkin IM; Litvinov VI; Il'ina IN; Kliuev VA
    Biull Eksp Biol Med; 1976 Jun; 81(6):719-21. PubMed ID: 953310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological tolerance and antituberculosis immunity].
    Averbakh MM; Litvinov VI; Markov AN; Il'ina NN
    Biull Eksp Biol Med; 1980 Feb; 89(2):198-200. PubMed ID: 7370422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polymer-metal complexes of the Mycobacterium protein antigen prevent the dissemination of postvaccinal infection in the T-deficiency state].
    Norimov ASh; Mustafaev MI; Romanova RIu; Abramenko TV
    Biull Eksp Biol Med; 1991 Feb; 111(2):180-1. PubMed ID: 1906761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed type hypersensitivity and antituberculous immunity.
    Averbakh MM; Gergert VY; Kluyev VA; Kolodiazhnaya NS; Litvinsov VI; Moroz AM
    Z Immunitatsforsch Exp Klin Immunol; 1974 Aug; 147(3):204-16. PubMed ID: 4283014
    [No Abstract]   [Full Text] [Related]  

  • 6. [The level and spectrum of antituberculosis antibodies in BCG-vaccinated mice and in mice and rabbits infected with a virulent mycobacterial culture].
    Markov AN; Nikonenko BV; Chernousova LN; Levi DT; Dem'ianenko NV; Litvinov VI
    Probl Tuberk; 1993; (1):43-4. PubMed ID: 8327439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
    Griffin JF; Chinn DN; Rodgers CR; Mackintosh CG
    Tuberculosis (Edinb); 2001; 81(1-2):133-9. PubMed ID: 11463234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low doses of recombinant interleukin-2 enhance delayed type hypersensitivity to PPD in mice infected with Mycobacterium bovis-BCG and fed a diet supplemented with vitamin A acetate.
    Ferraro F; Mattei M; Colizzi V
    Z Erkr Atmungsorgane; 1988; 171(1):45-9. PubMed ID: 3057751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfer of the cytotoxic activity of lymphocytes immune to M. tuberculosis].
    Averbakh MM; Kliuev VA; Litvinov VI
    Biull Eksp Biol Med; 1973 Jun; 75(6):76-9. PubMed ID: 4204961
    [No Abstract]   [Full Text] [Related]  

  • 11. [Development of protective antituberculosis immunity after BCG vaccination in mice with silicon deficiency in water and feed].
    Akuginova ZD; Akuginova GE; Mezhlumova MB; Avdienko VG; Nikonenko BV
    Probl Tuberk; 1995; (2):23-4. PubMed ID: 7777456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity.
    Derrick SC; Yang AL; Morris SL
    Vaccine; 2004 Dec; 23(6):780-8. PubMed ID: 15542202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. I. Suppression of delayed-type hypersensitivity].
    Nakamura RM; Goto Y; Kinomoto M
    Kekkaku; 1990 Sep; 65(9):581-4. PubMed ID: 2232436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study of the role of the T- and B-lymphocytes in tuberculosis immunity].
    Al'dzhambaev ShIu; Leĭkina LF; Morozov VL; Perchatkin VF; Dzhumabaev TD
    Probl Tuberk; 1983 Jan; (1):60-3. PubMed ID: 6340097
    [No Abstract]   [Full Text] [Related]  

  • 15. Neonatal thymectomy and tumor induction with methylcholanthrene in mice.
    Balner H; Dersjant H
    J Natl Cancer Inst; 1966 Mar; 36(3):513-21. PubMed ID: 18630325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of mice with Mycobacterium leprae/Mycobacterium bovis BCG admixtures: modulation of the acquired response to BCG.
    Orme IM
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):293-8. PubMed ID: 3298475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
    Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
    Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental investigations of the optimal therapy of systemic BCG infection in vivo].
    Jurczok A; Zacharias M; Böhle A; Fornara P; Jocham D
    Aktuelle Urol; 2004 Sep; 35(5):406-12. PubMed ID: 15368130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between immunopotency tests and specific active or passive acquired resistance against Mycobacterium tuberculosis in mice induced with three different preparations of BCG pasteur vaccine.
    Brandely M; Hurtrel B; Lagrange PH
    Clin Exp Immunol; 1983 Oct; 54(1):143-50. PubMed ID: 6413106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.